echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 14 large varieties with volume procurement results landed (with list)

    14 large varieties with volume procurement results landed (with list)

    • Last Update: 2020-09-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    13 selected enterprises, 16 pharmaceutical business (distribution) enterprises and Hefei, Anqing City public medical institutions with a joint lead unit Hefei City First People's Hospital, Anqing City Hospital signed a volume procurement of selected drugs purchase and sale contract, the results of the collection and selection on August 31 in Hefei City unified implementation.
    , 14 large varieties of strip procurement results officially entered the landing implementation phase.
    According to the Hefei Municipal Health Insurance Bureau, compared with the benchmark price published in the procurement documents, the highest decline of the selected varieties by 96%, an average decline of 67%, according to 14 varieties in the previous year in the Alliance region procurement amount of 153 million estimates, the annual savings in drug costs of about 120 million.
    in accordance with the provisions of Hefei, Anqing Union collection documents, the agreed procurement volume of this collection according to the annual commitment to purchase 70% of the determination, the current round of collection procurement cycle for one year.
    Hefei and Anqing Union began on June 15.
    collection documents clearly, according to the 2019 Hefei, Anqing Union region public medical institutions in the order of drug procurement amount, selected 14 clinical use of large, high procurement amount, full competition, clinical use of mature drugs to carry out centralized procurement.
    , the 14 drugs cover the digestive system, respiratory system, cardiovascular system, anti-infection and other therapeutic areas.
    July 7, Hefei, Anqing Alliance region 14 varieties of belt procurement into the pre-qualification stage of pharmaceutical enterprises, as many as 205 pharmaceutical companies through pre-qualification, the number of pharmaceutical companies to participate in the bidding can be described as numerous.
    July 17, 10 days later, Anqing City Health Insurance Bureau officially announced the "Hefei, Anqing Union regional drug concentration procurement results", Qilu, Koren, Rundu and other well-known pharmaceutical companies shortlisted.
    For the enterprise's entry requirements, in addition to clear the original research drugs and participation preparations can participate in the competition, Hefei, Anqing Alliance region of the collection documents do not require participation in the pharmaceutical enterprises related products must pass a consistent evaluation, replaced by the admission criteria is the main income ranking of pharmaceutical companies, procurement volume in the Alliance region, as well as enterprise capacity requirements, in general, is still favored domestic head pharmaceutical enterprises.
    the trend of local collection of unexamined varieties is clear, the progress of drug collection of spontaneous exploration is different.
    , unlike Hefei, Anqing Union region has entered the landing stage, some provinces and the Alliance region's volume procurement program began to solicit opinions.
    from the draft is that local harvesting of drugs that have not been consistently evaluated is becoming a mainstream trend.
    On August 26, Hainan Provincial Health Insurance Bureau issued the "Hainan Province 2020 drug centralized band procurement implementation plan (draft for comments)" proposed that in the clinical use of large, high procurement amount, full competition, clinical use mature, the same generic name has not yet been generic drugs through the quality and efficacy of consistent evaluation of drugs, through expert selection to determine the procurement varieties.
    August 28, the Shaanxi Provincial Health Insurance Bureau issued a "letter on the procurement of unre assessed drug band" outflow.
    The above-mentioned communication shows that, in order to further exert the scale effect of the inter-provincial alliance and promote the reduction of prices of medicines and medical supplies, Shaanxi intends to organize the procurement of unestailed drug belt volume, and Shaanxi requires the provinces interested in participating to confirm the letter by September 4.
    It is worth noting that Shaanxi has successfully organized the leadership of Ningxia, Gansu, Qinghai, Xinjiang, Xinjiang Construction Corps, Hunan, Guangxi, Guizhou, Hainan and other 10 provinces (regions, corps) alliance of high-value medical supplies artificial crystal procurement work.
    March 5, the Central Committee of the Communist Party of China and the State Council issued the Opinions on Deepening the Reform of the Medical Security System, which also explicitly calls for deepening the reform of the centralized belt procurement system for pharmaceuticals and medical supplies, and promoting the construction of a regional and national alliance procurement mechanism.
    According to the incomplete statistics of Cypress Blue, up to now, Fujian Sanming Alliance, Shandong Texas, Shandong Yantai, Shandong Jinan, Shandong Luze, Zhejiang Jinhua, Henan Puyang, Hubei Wuhan, Anhui Hefei and Anqing Alliance regions have begun to explore local volume procurement, and most regions have not set the consistency evaluation as the enterprise finalist requirements.
    June 5, the National Health and Safety Commission and other nine departments also jointly issued a clear message, will promote the implementation of non-assessment of drug belt procurement pilot.
    can be said that a single province, provincial alliance, municipal alliance for drugs that have not been consistent evaluation of the volume of procurement has become a clear trend.
    According to authoritative sources to Seber blue revealed that, in addition to the national organization for the consistent evaluation of drugs to carry out volume procurement, to encourage all regions to explore for drugs that have not been consistent evaluation of the collection of drugs for the reasons - although the national organization of drug collection price reduction results are significant, but due to the coverage of fewer varieties, in the specific practice of the drug squeeze not included in the national procurement of selected drugs.
    that is to say, some drugs that do not squeeze the price of water in the hospital is very competitive, and even there has been an impact on the selection of varieties in the hospital better landing situation.
    In order to reduce the burden of patients as soon as possible, but also in order to ensure the use of selected drugs, but also in order to reduce the state-owned drug enterprises included in the evaluation of the mentality of the imbalance, or for the next stage of the national organization of drug belt procurement exploration experience, the policy encourages local voluntary exploration of varieties that have not been consistent evaluation, to carry out collection.
    From the varieties collected in various places, the top clinical sales of injections are the main collection object, on the one hand, because the consistent evaluation of injections is relatively slow, on the other hand, because the general price of injections is high, and is the hospital's main dosage form.
    in this situation, enterprises need to realize that the number of manufacturers over-consistent evaluation is not sufficient, it can avoid the collection of safe havens.
    , consistent evaluation of slow-moving varieties, may face a series of price reduction pressure, first local collection, and then the national organization of drug collection.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.